Gli altri portali
Notizie a Confronto
Comunicati Stampa
Social News
Offerte di Lavoro
Comunicati Stampa
Sezioni
Toggle navigation
Prima pagina
Elenco
Nuovo account
Inserimento
Pannello di controllo
Modifica password
Salute e Benessere
Seleziona Categoria
Tutte le Categorie
Agricoltura
Ambiente
Arte e Cultura
Cibi e Bevande
Economia
Editoria e Media
Elettronica
Energia
Fiere ed Eventi
Industria
Information Technology
Internet
Istruzione e Formazione
Moda
Non Profit
Politica e Istituzioni
Salute e Benessere
Scienza e Tecnologia
Servizi
Società
Spettacolo
Sport
Telecomunicazioni
Trasporti
Turismo
Varie
Italiano
Inglese
Spagnolo
AB Science provides an update on the application for conditional marketing…
PRESS RELEASEAB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSISParis, 17 October, 2024, 7.30pm CETAB Science SA(Euronext - FR0010557264 - AB) today announces that the European Medicines Agency (EMA) confirmed a negative opinion for the conditional marketing authorization of masitinib in the treatment of amyotrophic lateral sclerosis (ALS), following a vote adopted during the...
Nasdaq GlobeNewswire
17/10/2024
Casino Group: Statutory buyout proceedings - Cnova
Casino has initiated statutory buyout proceedings in accordance with Article 2:92a of the Dutch Civil Codeto acquire all issued shares in Cnova Paris, 17 October 2024Casino Guichard-Perrachon S.A. (Euronext Paris: CO; ISIN: FR0000125585) hereby informs as follows: on 17 October 2024, Casino Guichard-Perrachon S.A. (" Casino ") has initiated statutory buyout proceedings ( uitkoopprocedure ) in accordance with Article 2:92a of the Dutch Civil Code (the " DCC ") at the…
Nasdaq GlobeNewswire
17/10/2024
OSE Immunotherapeutics Presents New “Cis-Demasking” Bispecific Technology for…
NANTES, France, October 17, 6:00pm CET - OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE), today announced it will be presenting its novel OSE-CYTOMASK Cis-Demasking 1cytokine technology in oral presentations selected for international conferences: TheFestival of Biologicsin Basel, Switzerland (October 17, 2024)The 16 thAnnualProtein & Antibody Engineering Summit (PEGS) Europe Summitin Barcelona, Spain (November 7, 2024)TheAntibody Therapeutics Xchange...
Nasdaq GlobeNewswire
17/10/2024
EssilorLuxottica: Q3/9M 2024 Revenue - Revenue keeping a solid 4% growth
Q3/9M 2024 RevenueRevenue keeping a solid 4% growth Group's revenue up 4.0% at constant exchange rates 1in Q3, +4.9% year to dateRevenue positive in both segments in all the regions in Q3North America up low-single digit, with sun retail turning positive at the end of the quarterEMEA up mid-single digit, driven by both Professional Solutions and Direct to ConsumerChina kept positive, despite macroeconomic headwinds, supported by Stellest 40% growthRay-Ban...
Nasdaq GlobeNewswire
17/10/2024
Allure Bridals Reveals Spring 2025 Collections
The namesake Allure Bridals collection continues its tradition of timeless elegance with romantic lacework that exudes classic beauty and warmth. The Allure Couture collection includes show-stopping styles with majestic detailing such as structured bodices and laced corsets. The addition of luxurious detachable sleeves and trains gives an opulent touch perfect for a regal look. Allure Romance's bridal looks feature floral motifs and refined textiles like Mikado and dove satin, while Chantilly…
PR Newswire
17/10/2024
Virbac: Strong revenue growth as of the end of September at +12.6% and +8.6% at…
KEY FIGURES Revenue at the end of September €1 042.1MGrowth at constant exchange ratesand scope 1 +8.6%including companion animals +11.9%farm animals +3.2%Growth at constantexchange rates 2 +14.0% Overallchange +12.6% 1 growth at constant exchange rates and scope corresponds to organic growth of sales, excluding exchange rate variations, by calculating the...
Nasdaq GlobeNewswire
17/10/2024
Casino Group: Appointments
Casino Group continues the overhaul of its purchasing strategy and organisationPauline Glaziou appointed Group Merchandise Director Paris, 17 October 2024 Pauline GLAZIOUhas been appointed Group Merchandise Director and will chair Casino Group's central purchasing unit as of 1 November 2024. She joins Casino Group's Executive Committee, where women are the majority following of this appointment.Pauline was previously Commercial Director of Food and Beauty at Monoprix, after having...
Nasdaq GlobeNewswire
17/10/2024
PCR Technologies Market Share Worth $24.52 Billion, Globally, by 2030 -…
Download Sample Report :https://www.theinsightpartners.com/sample/TIPRE00003069/ Competitive Strategy and Development Global Headlines on PCR Technologies Identify the Key Trends Affecting This Market - Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00003069/ Overview of Report Findings Market Segmentation Purchase Premium Copy of Global PCR Technologies Market Growth Report (2021-2031) at:https://www.theinsightpartners...
PR Newswire
17/10/2024
Body Contouring Treatments Market to Hit USD 2.58 Billion by 2029 with 10.0%…
Browse in-depth TOC on "Body Contouring Treatments Market"237 - Tables58 - Figures261 - Pages Browse in-depth TOC on "Body Contouring Treatments Market" 237 - Tables 58 - Figures 261 - Pages The body contouring treatments market is segmented based on technology into invasive and non-invasive technologies—the non-invasive segment is expected to hold major share of the market in 2023. The reduced risk of complications and rising awareness of the advantages of non-invasive...
PR Newswire
17/10/2024
Bioconjugation Market to Hit USD 10.86 Billion by 2029 with 15.6% CAGR |…
Browse in-depth TOC on "Bioconjugation Market" Browse in-depth TOC on "Bioconjugation Market" 1034 - Tables65 - Figures676 - Pages The market for bioconjugation has experienced significant growth also due to increasing investments in biopharmaceutical R&D, and growing demand for outsourcing services. The growing demand for biologics, such as monoclonal antibodies, antibody-drug conjugates (ADCs), and other protein-based drugs, is a major factor contributing to the...
PR Newswire
17/10/2024
Cancer: Crosetto's Breakthrough Inventions with Potential to Save Millions of…
They approved his six articles for presentation, their titles available at the conference program (https://www.eventclass.org/contxt_ieee2024/scientific/online-program/session?s=N-29), each supported by two pages accepted by reviewers, allocating Crosetto nearly two hours on October 31, 2024, 16:20 EST to present his 3D-Flow and 3D-CBS breakthrough inventions on particle detection and cancer detection at the world's most important conference in particle physics and medical imaging, in Tampa…
PR Newswire
17/10/2024
RenovaroCube Presents Novel Insights on Non-Invasive Cancer Diagnostics Using…
(NASDAQ: RENB)– RenovaroCube, a leader in AI-driven cancer diagnostics by integrating multi-omics with liquid biopsies, is excited to announce the presentation of its latest research at the Molecular Analysis for Precision Oncology Congress – on October 16, 2024.This study investigates the use of Oxford Nanopore sequencing on circulating cell-free DNA (cfDNA) derived from blood plasma to detect key copy number alterations (CNAs) in lung cancer patients. CNAs are a key hallmark of cancer...
Nasdaq GlobeNewswire
17/10/2024
Essity has received a demand for early repayment of bonds
NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out below, at 13:15 CET on October 17, 2024. NB:This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact person set out...
PR Newswire
17/10/2024
Endo Announces Seven New Presentations at the Sexual Medicine Society of North…
The seven Endo-sponsored and Endo-supported presentations are below: The seven Endo-sponsored and Endo-supported presentations are below: Sponsored by Endo: Investigator-Initiated Research: About Peyronie's DiseasePeyronie's disease (PD) is a condition in which a buildup of fibrous scar tissue causes a curvature deformity of the penis. This curvature can be painful during arousal and intimacy. 1It is estimated that PD can affect as many as 1 in 10 men in the U.S., 2but...
PR Newswire
17/10/2024
Fortrea Releases Inaugural Corporate Social Responsibility Report
Fortrea (Nasdaq: FTRE), a leading global contract research organization (CRO), today announced the release of the company's inaugural Corporate Social Responsibility report, “ Fortrea for Better.” Available for download onFortrea.com, the report describes Fortrea's environmental, social and governance (ESG) activities, reported across four distinct sections: Fortrea forLife : Responsible Environmental PracticesFortrea forAll : Responsible People PracticesFortrea forGood :...
Nasdaq GlobeNewswire
17/10/2024
Amplo Biotechnology Announces Three Presentations at the European Society of…
Details for the poster presentations: Details for the poster presentations: Abstract Title: Development of a platform gene therapy approach for Congenital Myasthenic SyndromesPresenting Author: Patricio V. Sepulveda S., PhD MBADate: Tuesday, October 22, 2024 Abstract Title:Pre-clinical development of gene augmentation therapy to restore Acetylcholinesterase activity in Collagen Q Congenital Myasthenic Syndrome using a platform approach to AAV gene therapy development...
PR Newswire
17/10/2024
KFSHRC Showcases Its Innovations and Health Solutions at the Global Health…
RIYADH, Saudi Arabia, Oct.17, 2024(GLOBE NEWSWIRE) -- King Faisal Specialist Hospital & Research Centre (KFSHRC) will participate as a Platinum Sponsor in the Global Health Exhibition 2024, held in Riyadh from October 21 to 23. Through its pavilion, KFSHRC will present its latest health innovations and solutions, showcasing their impact on improving healthcare outcomes, patient experience, and operational efficiency. These include robotic heart surgery, organ transplantation, CAR-T...
Nasdaq GlobeNewswire
17/10/2024
MolecuLight's Fluorescence Imaging: A Game-Changer for Bedside Biofilm Detection
"Fluorescence imaging demonstrated superior sensitivity (84%) compared to traditional methods of bedside biofilm detection," says Anil Amlani, CEO of MolecuLight Inc. "This underscores the transformative impact of our technology in managing a crucial issue affecting the outcomes of chronic wounds by providing clinicians with real-time, objective data that can significantly enhance patient outcomes." "Fluorescence imaging demonstrated superior sensitivity (84%) compared…
PR Newswire
17/10/2024
AscellaHealth Announces its Strategic Acquisition of CHAPPER healthcare: Expands…
AscellaHealth , a global partner delivering customizable solutions to support the specialty pharmaceutical industry, announces the acquisition of CHAPPER healthcare , a global specialty pharmaceutical wholesaler, distributor and services provider established in 1975. The acquisition of this recognized leader in the import and export of specialty pharmaceuticals deepens AscellaHealth's capabilities to serve international manufacturers and patients in more than 70 countries across the EU,...
Nasdaq GlobeNewswire
17/10/2024
Hisense Announces Dual Carbon Pledge at ESG Global Leaders Conference
"Hisense has embraced a 'long-termism' principle of implementing ESG practices as part of our 'Comprehensive Layout' and 'Global Action' strategy, which are integral to the company's commitment to ESG development," explained Mr. Jia. "The company has established a global network of '5+1' regional centers for research, production and sales. This adheres to a 'Local for Local' principle to contribute to and serve local communities, whilst reducing logistics costs and energy…
PR Newswire
17/10/2024
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
Tom Loewald, Cambrex CEO, stated, "After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important milestone in the growth of Q1 Scientific." Tom Loewald, Cambrex CEO, stated, "After acquiring Q1 Scientific in 2022, we have strategically expanded our footprint to best serve our clients worldwide. This first North American facility opening marks an important…
PR Newswire
17/10/2024
Finnish municipality has chosen Aino
Yet another Finnish municipality, Siilinjärvi, has chosen Aino's SaaS platform to be more socially sustainable and to achieve the operational goals with the existing staff. The agreement includes a total of 850 employees and the SaaS platform is in production use since the third quarter of 2024. “As a public organization we are working hard every day to find and to keep employees with the right competence. With Aino we will gain a more systematic and responsive leadership, boost employee...
Nasdaq GlobeNewswire
17/10/2024
CSL Vifor and Travere Therapeutics Announce Swissmedic approval of FILSPARI®…
"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice President and Head of Global Regulatory Affairs at CSL. "There is a high unmet medical need for a targeted therapy to treat IgAN and we look forward to providing access to this innovative treatment option for the Swiss IgAN community as fast as possible. Thank you to all of the patients…
PR Newswire
17/10/2024
Bio X Cell Announces Board of Director Appointments
"We are thrilled to welcome Alan Hirzel to the board alongside Kevin Ballinger, who joined earlier this year," said Chris Conway, CEO of Bio X Cell. "Alan and Kevin bring a wealth of experience and industry knowledge to the table, which will serve us well as we execute on BXC's extraordinary strategic growth opportunities following the Company's recent acquisition by Windjammer Capital Investors." "We are thrilled to welcome Alan Hirzel to the board alongsideKevin…
PR Newswire
17/10/2024
Altri Comunicati
